
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded capsule containing melatonin, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No FDA-approved (NDA or ANDA) product containing melatonin is listed. Products containing it are filed in the directory as homeopathic products, in liquid, solution, pellet, tablet and spray forms. None of the listed products containing melatonin is in capsule form.
This is a solid, nonaqueous dose form. Under USP <795>, nonaqueous preparations carry longer default beyond-use dates than water-containing ones. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Melatonin is a sleep-regulating hormone sold in the US as a dietary supplement; compounding pharmacies prepare it in oral forms by prescription.
Melatonin is a hormone the pineal gland makes in response to darkness. It acts on MT1 and MT2 receptors and signals the brain's master clock in the hypothalamus, which helps set circadian rhythm and promote sleep. Supplements are usually synthetic. In the United States melatonin is sold as a dietary supplement, which the FDA regulates less strictly than drugs, and StatPearls notes it is not FDA-approved for any indication; related prescription drugs, ramelteon and tasimelteon, are melatonin receptor agonists. NCCIH reports that supplement labels are often inaccurate, with one study finding most gummy products mislabeled. A prescriber might order melatonin compounded in a specific strength, an immediate- or slow-release form, a liquid for a child, or an allergen-free vehicle. Compounded preparations are not FDA-approved and require a prescription.
Melatonin has no FDA drug label or boxed warning. NCCIH says short-term use appears safe for most adults, but long-term data are lacking. Reported side effects include headache, dizziness, nausea and daytime sleepiness; in children, increased bedwetting or urination in the evening and agitation have been noted. In older adults it may stay active longer and cause daytime drowsiness, and guidelines advise against it in people with dementia. Combining it with sedatives such as benzodiazepines or zolpidem may cause oversedation, and fluvoxamine can raise melatonin levels. People with epilepsy or on blood thinners need medical supervision. Research in pregnancy is limited. LactMed notes no safety data in breastfeeding but considers short-term evening use unlikely to harm a breastfed infant. Store it out of children's reach; CDC estimated about 11,000 emergency visits for accidental ingestion by young children from 2019 to 2022. Talk to your prescriber or pharmacist about side effects.
Exogenous melatonin mimics the endogenous hormone, which is synthesized from serotonin via the rate-limiting enzyme arylalkylamine N-acetyltransferase and acts at MT1 and MT2 receptors. Per StatPearls, oral bioavailability varies widely from 1% to 74% depending on formulation, protein binding is about 61% to 78%, about 90% is metabolized in the liver mainly by CYP1A2 (minor CYP2C19) to 6-hydroxymelatonin and excreted in urine as conjugates, and the elimination half-life is about 1 to 2 hours. There is no FDA-approved melatonin product. StatPearls notes that AASM endorses melatonin for REM sleep behavior disorder and circadian rhythm disorders and that it has been studied for insomnia, jet lag, shift work, migraine prophylaxis and neurodegenerative conditions; NCCIH reports AASM and ACP guidelines found insufficient evidence for chronic insomnia. Use caution with potent CYP1A2 inhibitors such as fluvoxamine, other sedative-hypnotics, autoimmune disease and transplant recipients, as melatonin stimulates immune function. Monitor sleep response, daytime sedation and headache. Dosing is per prescriber. Melatonin is not a controlled substance.
Swallow each capsule whole with a glass of water, unless your label says otherwise. Do not crush, chew or open the capsule unless your pharmacist tells you it is safe to do so. Take it at the times shown on your prescription label. If you miss a dose or are unsure how to take it, call the pharmacy.
Capsules are nonaqueous, so under USP <795> they usually carry a beyond-use date of up to 180 days when no other stability data apply. Keep the vial tightly closed at room temperature, away from heat, moisture and direct light, and out of reach of children. Discard any capsules left after the beyond-use date on the label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth